AF
NVCR icon

Allworth Financial’s NovoCure NVCR Stock Holding History

Allworth Financial’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.5K Buy
965
+255
+36% +$3.19K ﹤0.01% 3461
2025
Q4 		$9.18K Sell
710
-254
-26% -$3.26K ﹤0.01% 3326
2025
Q3 		$12.5K Buy
964
+328
+52% +$4.38K ﹤0.01% 3000
2025
Q2 		$11.3K Buy
636
+300
+89% +$5.23K ﹤0.01% 2835
2025
Q1 		$6.23K Sell
336
-92
-21% -$2.09K ﹤0.01% 2645
2024
Q4 		$11.5K Buy
428
+7
+2% +$148 ﹤0.01% 2382
2024
Q3 		$6.58K Sell
421
-25
-6% -$453 ﹤0.01% 2447
2024
Q2 		$8.21K Sell
446
-602
-57% -$10.6K ﹤0.01% 2309
2024
Q1 		$16.4K Sell
1,048
-25
-2% -$368 ﹤0.01% 1884
2023
Q4 		$16K Buy
1,073
+929
+645% +$12.4K ﹤0.01% 1761
2023
Q3 		$2.33K Buy
+144
New +$4.15K ﹤0.01% 2464
2023
Q2 		– Sell
-33
Closed -$1.99K – 3336
2023
Q1 		$1.99K Sell
33
-185
-85% -$14.8K ﹤0.01% 2415
2022
Q4 		$16K Sell
218
-19
-8% -$1.43K ﹤0.01% 1483
2022
Q3 		$18K Buy
237
+28
+13% +$2.18K ﹤0.01% 1344
2022
Q2 		$15K Buy
209
+206
+6,867% +$15.5K ﹤0.01% 1369
2022
Q1 		$0 Sell
3
-186
-98% -$13.7K ﹤0.01% 2291
2021
Q4 		$14K Buy
189
+105
+125% +$10.5K ﹤0.01% 1268
2021
Q3 		$10K Buy
+84
New +$12.7K ﹤0.01% 1339

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Allworth Financial's NVCR Position: Q1 2026 in Review

Allworth Financial increased its NovoCure (NVCR) stake by 36% in Q1 2026, buying an estimated $3.19K and bringing the position to 965 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3461.

Allworth Financial first reported a position in NVCR in Q3 2021 and has held it in 18 quarters since. The position peaked at $18K in Q3 2022. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Allworth Financial held 965 shares of NovoCure worth $10.5K as of Q1 2026.
  • Allworth Financial bought 255 NovoCure shares in Q1 2026, an estimated $3.19K.
  • NovoCure made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #3461 holding.
  • Allworth Financial first reported a position in NovoCure in Q3 2021 and has held it in 18 quarters since.
  • Allworth Financial's NovoCure position peaked at $18K in Q3 2022.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.